Manja Bloem

Aug 14, 2024 | jamanetwork.com | Amsterdam UMC |Manja Bloem |John B. Haanen |Hilde Jalving

Key PointsQuestion  What are the long-term outcomes of patients with advanced melanoma who are treated in daily clinical practice, and do they have a chance of sustaining long-term survival? Findings  In this cohort study including 2490 patients with advanced melanoma treated with first-line immune checkpoint inhibitors, survival curves flattened over time, suggesting long-term survival.